定制开窗分支支架腔内修复胸腹主动脉瘤的多中心经验
本研究回顾性分析了6个欧洲中心108例胸腹主动脉瘤患者,使用E-xtra Design Engineering定制开窗分支支架进行腔内修复。技术成功率95%,30日死亡率9.2%,围术期脊髓缺血5.5%(永久性1.8%)。平均随访17.6个月,26%患者需晚期再干预,1、2、4年生存率分别为87%、84%、51%,目标血管通畅率分别为95%、91%、90%。结论认为该技术早中期安全有效,但再干预率较高,需加强随访。
要点
- 定制开窗分支支架修复胸腹主动脉瘤技术成功率95%,30日死亡率9.2%。
- 围术期脊髓缺血发生率5.5%,其中永久性1.8%。
- 平均随访17.6个月,26%患者需晚期再干预,4年免于再干预率73%。
核心结论
- 使用Jotec定制开窗分支支架腔内修复胸腹主动脉瘤在早中期似乎安全有效。
- 较高的二次干预率提示需要进一步改进、移植物监测和随访。
研究设计与样本
- 回顾性多中心队列研究,纳入2011年11月至2017年1月期间6个欧洲区域外科中心连续108例胸腹主动脉瘤患者。
- 患者平均年龄73.5岁,男性73例;中位动脉瘤直径6.75 cm(范围5.5-13)。
- 胸腹主动脉瘤按改良Crawford分型:I型25例(24%)、II型19例(17%)、III型20例(18%)、IV型29例(27%)、V型15例(14%)。
主要发现
- 技术成功率达95%(103/108)。
- 主要早期围术期并发症发生于40例(37%)患者。
- 30日死亡率为9.2%(10/108),围术期脊髓缺血见于6例(5.5%),其中永久性2例(1.8%)。
- 平均随访17.6个月(范围3-52),28例(26%)患者需要晚期再干预;2例死于动脉瘤或手术相关原因。
- 估计1、2、4年生存率分别为87%、84%、51%;同期目标血管通畅率分别为95%、91%、90%;1年和4年免于再干预率分别为84%和73%。
临床怎么用
- 对于适合解剖条件的胸腹主动脉瘤患者,可考虑使用定制开窗分支支架进行腔内修复。
- 术后需密切监测内漏、再干预及目标血管通畅性,并加强长期随访。
局限性
- 回顾性研究设计,样本量有限(108例),随访时间较短(平均17.6个月)。
- 缺乏与开放手术或其他腔内技术的对照比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the outcomes of patients who were treated for thoracoabdominal aortic aneurysms (TAAAs) using custom-made fenestrated-branched stent-grafts. METHODS: A consecutive series of 108 patients (mean age 73.5 years; 73 men) with TAAA were treated with E-xtra Design Engineering customized fenestrated-branched stent-grafts between November 2011 and January 2017. Data on baseline characteristics, procedures, and clinical follow-up were collected from 6 regional European surgical centers for retrospective analysis of endoleaks, reinterventions, and target vessel patency. The median aneurysm diameter was 6.75 cm (range 5.5-13). The distribution of the TAAA according to the modified Crawford classification of extent was 25 (24%) type I, 19 (17%) type II, 20 (18%) type III, 29 (27%) type IV, and 15 (14%) type V. RESULTS: Technical success was achieved in 95% (103/108) of cases. Major early perioperative complications occurred in 40 (37%) patients. The 30-day mortality was 9.2% (10/108), and perioperative spinal cord ischemia was observed in 6 (5.5%) patients [2 (1.8%) permanent]. During the mean follow-up of 17.6 months (range 3-52), 28 (26%) patients required late reintervention. Two patients died due to aneurysm- or procedure-related causes. The estimated survival rates at 1, 2, and 4 years were 87%, 84%, and 51%, respectively. The estimated target vessel patency rates at the same time points were 95%, 91%, and 90%, respectively. The freedom from reintervention estimates were 84% and 73% at 1 and 4 years, respectively. CONCLUSION: Endovascular repair of TAAA using Jotec customized fenestrated-branched stent-grafts appears to be safe and effective in the early to midterm. The considerable rate of secondary interventions indicates that further improvements, graft surveillance, and follow-up are required.
引用
- Youssef M, Deglise S, Szopinski P, et al. A Multicenter Experience With a New Fenestrated-Branched Device for Endovascular Repair of Thoracoabdominal Aortic Aneurysms. J Endovasc Ther. 2018. PMID: 29313454. doi:10.1177/1526602817752147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。